Skip to main content
. 2020 Dec 10;15:277. doi: 10.1186/s13014-020-01723-z

Fig. 4.

Fig. 4

The RBE-weighted dose distribution (three dose lines) from a patient with rNPC in LEM plan (a), the dose distribution in recalculated MKM plan (b) and the dose distribution using the conversion curve in MKM plan (c); b and c are nearly identical